Repligen (RGEN) Reports In-Line Q3 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
- Shipping stocks on fire — but cracks are forming in the rate rally
Repligen Reports Third Quarter 2015 Financial Results
November 5, 2015 7:31 AM EST- Product Sales Increase 31% to $19.8 Million -
- Conference Call and Webcast Today at 8:30 a.m. ET -
WALTHAM, Mass., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for the third quarter and nine-month (year-to-date) periods ended September 30, 2015. Below are the Companys performance highlights, followed by updated financial guidance for the year 2015 and access information for todays webcast and conference call.
Third Quarter and Year-to-Date Financial... More
